Epsilogen: Valuation, Funding & Investors
A biotech leader focused on developing immunoglobulin E (IgE) antibodies for cancer therapy.
Leadership & Board
- Current Number of Employees
- 33
- Current LinkedIn Followers
- 3,943
Latest Estimated Valuation
- Total Amount Raised
- $16M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $16M
- Latest Funding Round
- Investment
Employee Trend
Epsilogen had 33 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
33Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Epsilogen had 3,943 followers as of October 26, 2026. The number of followers increased by 7 (0.18%) week-over-week.
3,943Latest Followers Count
7(0.18%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 19, 2025 | Investment | $16.40M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| British Patient Capital | Investment |
| Novartis Venture Fund | Investment |
| Epidarex Capital | Investment |
| 3B Future Health Fund | Investment |
| ALSA Ventures | Investment |
Similar Companies
A snapshot of private companies similar to Epsilogen, helping you discover and navigate related company profiles.
